OS

OssDsign ABFNSE OssDsign Stock Report

Last reporting period 30 Jun, 2024

Updated 21 Oct, 2024

Last price

Market cap $B

0.067

Micro

Exchange

FNSE - First North Sweden

OSSD.ST Stock Analysis

OS

Uncovered

OssDsign AB is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

-12/100

Low score

Market cap $B

0.067

Dividend yield

Shares outstanding

71.343 B

OssDsign AB is a holding company, which designs, manufactures, and sells implants and material technology for bone regeneration. The company is headquartered in Uppsala, Uppsala. The company went IPO on 2019-05-24. The company aims at developing implantable products that respond to clinical challenges, with focus on bone healing. Its primary focus is skull surgery. The firm uses design solutions, material compositions and manufacturing processes mainly based on proprietary bioceramic technologies. The bioceramics it uses integrate with tissues and support bone ingrowth. OssDsign AB's main product is Craniomosaic, an implant for the repair of skull defects (cranioplasty). Along with it, the Company develops bioceramic implants for facial bone augmentation. The firm's customers include neurosurgeons, craniofacial and maxillofacial surgeons.

View Section: Eyestock Rating